1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

For People Wanting to Lose Body Fat, FDA Approves Zeltiq Procedure To Remove Fat Without Surgery

The Zeltiq Procedure gently cools unwanted fat cells at specific areas of the body, causing them to shrink and gradually be eliminated from the body. Co-invented by a Miami doctor via Harvard, his wife is the only dermatologist to offer it in Miami.

 
PRLog - Sep. 16, 2010 - Miami, Fla. — There’s been a major development for people who can’t get rid of body fat in some of the most stubborn areas. The technique known as “CoolSculpting” has been approved by the U.S. Food and Drug Administration for the non-invasive reduction of fat.

Body fat can be combated with cold. This new technology, being offered for the first time in Miami, takes advantage of that fact to trim love handles and belly fat – without surgery.

Bowes Dermatology Group of Miami has been involved in early clinical treatments for the Zeltiq Cryolipolysis device for fat layer reduction and introduced it in Miami. Bowes is the only practice in Miami to offer the treatment. The Zeltiq Procedure gently cools unwanted fat cells at specific areas of the body, causing them to shrink and gradually be eliminated from the body.

The procedure for non-invasive fat layer reduction is available on a limited basis in Canada, the European Union and other international markets. The Zeltiq device itself had been previously cleared (for several months) by the FDA for various applications related to skin cooling during dermatologic treatments. The procedure for non-invasive fat layer reduction was cleared Sept. 8 by the FDA.

"It's the most exciting technology we've seen in decades, and the first technology that effectively reduces fat without surgery," says Leyda Bowes, MD, a board-certified dermatologist. She reports she has found the device to be extremely effective on fat bulges and “pads”, areas that do not respond to diet and exercise. “It’s especially effective on resistant localized areas such as back fat, love-handles and isolated belly fat,” Dr. Bowes says.

Dr. Bowes’ husband, Dr. Dieter Manstein, is the co-inventor of the selective cryolipolysis for body contouring procedure. Dr. Manstein also practices in Bowes’ Miami office.

The Zeltiq technique is based on science developed by Dr. Manstein and a colleague at Massachusetts General Hospital in Boston, a teaching affiliate of  Harvard Medical School. They discovered that fat cells are more susceptible to cold than other cells and can be selectively, painlessly and permanently destroyed. Starting several weeks after the procedure, cooled fat cells begin a process called ‘apoptosis’ and begin to shrink and disappear. The body absorbs the damaged fat cells and removes them as is normal through the liver.

“The procedure is non-invasive, absolutely painless, and offers noticeable results,” says Dr. Bowes. “Early patients who tried it were highly satisfied.”

The Zeltiq procedure involves no needles, surgery or downtime. A non-invasive applicator targets the area of fat to be treated with precisely controlled cooling. Treatment cycles last one hour and, depending on the area treated, patients typically require two to four treatment sessions.

Afterwards, the cooled fat gradually shrinks and is eliminated from the body over a period of two to six months in most patients. Clinical studies have shown that the Zeltiq Procedure can reduce 1 to 2 cm of the selected fat layer thickness (up to 22.4% of the targeted fat layer) within two to four months post-procedure after a single treatment.

Bowes Dermatology offers the Zeltiq Procedure as part of its menu of treatments. Dr. Bowes notes that the Zeltiq Procedure fills a need between cosmetic and surgical treatments.

“It’s helpful for difficult areas like love handles and areas of the stomach where exercise and nutrition are just not enough. It’s not intended for weight reduction, nor will it replace certain other procedures, such as traditional liposuction for more pronounced results in patients with excessive fat areas.

“But the Zeltiq Procedure targets the fat layer while being non-invasive and so comfortable that patients just read or work on their laptops during treatment, then return to their normal activities the same day,” she adds.

Dr. Bowes is a board certified cosmetic dermatologist and dermatologic surgeon in private practice in Miami. She received both her Bachelor of Science and Doctor of Medicine degrees from the University of Miami. Dr. Bowes also was awarded a fellowship in cosmetic dermatologic surgery from the American Academy of Cosmetic Surgery in La Jolla, Ca., and completed a two-year laser fellowship at the Massachusetts General Hospital Department of Dermatology in Boston, Ma. She maintains a practice staffed by other skin professionals who provide a range of skin healthcare services.

Dr. Manstein is the co-inventor of the Cryolipolysis principle for body contouring. He received his Ph.D from the University of Munster in Germany and a fellowship in Clinical Applications of Lasers from the Harvard Medical School Wellman Center for Photomedicine. Since 2004, Dr. Manstein has been a faculty member in the Massachusetts General Hospital Department of Dermatology/Harvard Medical School.

For more information, please visit:  http://www.bowesdermatology.com.

--- End ---

Click to Share

Contact Email:
***@carpenterpr.com Email Verified
Source:Scott Carpenter
City/Town:Miami - Florida - United States
Industry:Health, Medical, Weight loss
Tags:bowes dermatology, zeltiq, fat reduction, miami, fda approved, dr. dieter manstein, dr. leyda bowes, non-invasive
Shortcut:prlog.org/10936271
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share